More people die from lung cancer than any other type of cancer. At Johns Hopkins, our goal is to reduce that number every year, working toward a day when no one will die from lung cancer. As we work toward that goal, we also focus our experience and expertise on preventing, screening for, diagnosing, and treating lung cancer in ways that give our patients the best possible prognosis.
Free Online Seminar
Early diagnosis and coordinated care make all the difference in lung cancer treatment. Watch Now
Dr. Charles Rudin discusses how lung cancer is treated by knowing the genetic makeup of your cells. Watch Now
Early Detection and Lung Cancer
Dr. Phil Dennis discusses improved ways to detect cancer at earlier stages. Watch Now.
Our comprehensive program includes:
- A team of lung cancer experts, including medical oncologists, radiation oncologists, thoracic surgeons, pulmonologists, pulmonary interventionists, nurse practitioners, radiologists, respiratory therapists, palliative care staff, medical informaticists, physical therapists, and nurses.
- A multidisciplinary clinic that gives patients a one-day treatment planning session with the lung cancer specialists who will be part of their treatment.
- A screening clinic, which give those at risk of developing lung cancer the tools, information, and support they need to prevent cancer from occurring or to catch it in its earliest stages.
- A research program, which is pioneering new therapies to target the molecular changes in lung cancer that make it grow and spread and examining the use of biomarkers to create personalized therapies for each patient.
- An emphasis on specialization and depth of experience. The lung cancer program staff is devoted to treating lung cancer. Day in and day out experience adds up to specialization that is rare in cancer treatment. The staff also has multiple opportunities to meet with colleagues across medical disciplines to discuss cases and hear about the latest research, clinical trials, and best practices.